China
FCC Doing ‘a top to bottom review of every’ Chinese Telecom Company In US, Says Commissioner Carr
FCC Commissioner Brendan Carr told The Sara Carter Show Monday that the Federal Communications Commission will proceed with the Department of Justice’s recommendation to fully investigate China Telecom Corp. over alleged espionage and is now conducting a top to bottom review of every single Chinese company operating in the United States telecommunications networks.
Amid concerns over Chinese failure to warn the world about the coronavirus pandemic, the DOJ on Thursday, issued a statement noting that interested “Executive Branch agencies unanimously recommended that the Federal Communications Commission (FCC) revoke and terminate China Telecom (Americas) Corp.’s authorizations to provide international telecommunications services to and from the United States.”
China Telecom, a U.S. subsidiary of a People’s Republic of China, is a state-owned telecommunications company of the communist government.
Carr said the Department of Justice’s recommendation that the FCC revoke the authority of China Telecom to connect to our telecommunications networks is currently being reviewed. He noted that years ago, under differing circumstances “China Telecom was authorized to connect to America’s telecom network.”
“What does that mean if you’re making a phone call or other data transmission from let’s say L.A. to D.C.? Well you may not know it but in that transmission path China Telecom could have a line in once that traffic hits the China Telecom line it has the potential to re-route that traffic back to China before then delivering it to D.C..”
“And we’ve seen some of that calls from L.A. go to China first then to D.C.,” Carr noted. “That’s not the most direct route. That gives us reason for concern and that’s why we’ve been taking concerted action at the FCC to stop new companies that are responding to the communist regime from connecting and why DOJ has recommended that we look at those companies that are already here.”
Last week, Carr took the Chinese government at their word stating to Chinese government spokesperson Hua Chunying on Twitter, that if the communist government has nothing to hide then he would like to speak with ‘disappeared citizen journalists’ and doctors from China who blew the whistle on the Chinese government and the Coronavirus outbreak in Wuhan.
2. Next, I’d like to speak with Chen Qiushi and Fang Bin – two video bloggers that tried to bring the world a glimpse of Wuhan unfiltered by your Communist regime.
Could you un-disappear them so we could speak?https://t.co/0ndiKKjQYZ
— Brendan Carr (@BrendanCarrFCC) April 10, 2020
The DOJ said Thursday that it led the review of China Telecom’s authorizations. It based the recommendations on developments since the authorizations were last transferred in 2007, including China Telecom’s failure to comply with the terms of an existing agreement with the Department, according to the statement.
“Today, more than ever, the life of the nation and its people runs on our telecommunications networks,” said John C. Demers, Assistant Attorney General for National Security. “The security of our government and professional communications, as well as of our most private data, depends on our use of trusted partners from nations that share our values and our aspirations for humanity. Today’s action is but our next step in ensuring the integrity of America’s telecommunications systems.”
When this reporter asked Carr “are you going to do it, do you think that you’re going to go right up on DOJ recommendations in an effort to squash China Telecom’s authorizations and work in the United States?”
Carr said, “we will certainly take up the recommendation and probably issue a show cause order here which would allow China Telecom some process to make their case -that’s why they think DOJ is wrong and then we’ll reach an ultimate decision very quickly.”
“I also think we should be reviewing and I’ve called for this and in some ways we’re already doing it a top to bottom review of every single company that could be controlled by the communist regime and where they should be continue to allow to connect to our network,” Carr added.
Carr stated that the Trump Administration has changed course from the approach taken by the Obama Biden administration, saying it was imperative that “we need to fundamentally rearrange our relationship with China.”
“You’re seeing it on the trade front you’re seeing on telecom with whether it’s China Telecom or Huawei or ZTE,” he told this reporter. “We are finally showing some strength whereas the prior approach was weak…And I think we have rightly shifted and I think COVID19 it is going to continue to turn us towards a stronger posture with China.”
During the podcast, Carr slammed China’s communist government’s response in covering up the coronavirus pandemic and its disappearing of many citizen journalists who warned early on about the severity of the virus. Looking ahead, he said that U.S. will need to fundamentally change our relationship with China.
Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.
Foreign Desk News writes:
Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.
“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.
Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.
“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.
The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4
— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023
Foreign Desk News adds:
The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.
-
Economy5 days agoNew York City Mayor Eric Adams Proposes Housing Asylum Seekers in Private Homes
-
Economy5 days agoTexas Gov Abbott aims to eliminate property taxes: ‘we must dream big’
-
Immigration4 days agoBiden Administration to allow 40,000 asylum-seekers per month into US with mobile app
-
Featured2 days agoLas Vegas Backyard UFO Encounter and Its Connection to Historic UFO Incidents
